These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 12574580)

  • 1. Acetylcholinesterase inhibitors for vascular dementia and Alzheimer's disease combined with cerebrovascular disease.
    Bowler JV
    Stroke; 2003 Feb; 34(2):584-6. PubMed ID: 12574580
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparison of donepezil and galantamine in the treatment of cognitive symptoms of Alzheimer's disease: a meta-analysis.
    Harry RD; Zakzanis KK
    Hum Psychopharmacol; 2005 Apr; 20(3):183-7. PubMed ID: 15700322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomized trial.
    Kertesz A
    Curr Neurol Neurosci Rep; 2002 Nov; 2(6):503-4. PubMed ID: 12359103
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomized trial.
    Marder K
    Curr Neurol Neurosci Rep; 2002 Sep; 2(5):389-90. PubMed ID: 12169216
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of vascular dementia-evidence from clinical trials with cholinesterase inhibitors.
    Erkinjuntti T; Román G; Gauthier S
    Neurol Res; 2004 Jul; 26(5):603-5. PubMed ID: 15265282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The use of galantamine in Alzheimer's disease associated with vascular dementia (according to the study of T. Erkinjuntti group)].
    Damulin IV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(5):65-7. PubMed ID: 19938276
    [No Abstract]   [Full Text] [Related]  

  • 7. For debate: is the evidence for the efficacy of cholinesterase inhibitors in the symptomatic treatment of Alzheimer's disease convincing or not?
    Ames D; Kaduszkiewicz H; van den Bussche H; Zimmermann T; Birks J; Ashby D
    Int Psychogeriatr; 2008 Apr; 20(2):259-92. PubMed ID: 18252031
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative analysis of mortality in patients with Alzheimer's disease treated with donepezil and galantamine.
    Capellà D; Vidal X
    Age Ageing; 2007 Mar; 36(2):234; author reply 235. PubMed ID: 17255086
    [No Abstract]   [Full Text] [Related]  

  • 9. [Medical treatment of Alzheimer's disease].
    Johannsen P
    Ugeskr Laeger; 2006 Oct; 168(40):3424-9. PubMed ID: 17032609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive decline and treatment options for patients with vascular dementia.
    Erkinjuntti T
    Acta Neurol Scand Suppl; 2002; 178():15-8. PubMed ID: 12492787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of donepezil treatment on cardiovascular mortality.
    Sato K; Urbano R; Yu C; Yamasaki F; Sato T; Jordan J; Robertson D; Diedrich A
    Clin Pharmacol Ther; 2010 Sep; 88(3):335-8. PubMed ID: 20664535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Galantamine for vascular cognitive impairment.
    Birks J; Craig D
    Cochrane Database Syst Rev; 2006 Jan; (4):CD004746. PubMed ID: 23862185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of vascular dementia--evidence from clinical trials with cholinesterase inhibitors.
    Erkinjuntti T; Román G; Gauthier S
    J Neurol Sci; 2004 Nov; 226(1-2):63-6. PubMed ID: 15537522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trial.
    Erkinjuntti T; Kurz A; Gauthier S; Bullock R; Lilienfeld S; Damaraju CV
    Lancet; 2002 Apr; 359(9314):1283-90. PubMed ID: 11965273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The long-term efficacy and tolerability of donepezil in patients with vascular dementia.
    Wilkinson D; Róman G; Salloway S; Hecker J; Boundy K; Kumar D; Posner H; Schindler R
    Int J Geriatr Psychiatry; 2010 Mar; 25(3):305-13. PubMed ID: 19623601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AD2000: donepezil in Alzheimer's disease.
    Schneider LS
    Lancet; 2004 Jun; 363(9427):2100-1. PubMed ID: 15220027
    [No Abstract]   [Full Text] [Related]  

  • 17. Galantamine for vascular cognitive impairment.
    Craig D; Birks J
    Cochrane Database Syst Rev; 2006 Jan; 2006(1):CD004746. PubMed ID: 16437493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Donepezil in Alzheimer's disease and vascular dementia].
    Damulin IV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(7):71-5. PubMed ID: 24073452
    [No Abstract]   [Full Text] [Related]  

  • 19. Cholinesterase inhibitors in the clinical management of Alzheimer's disease: importance of early and persistent treatment.
    Seltzer B
    J Int Med Res; 2006; 34(4):339-47. PubMed ID: 16989488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are cholinesterase inhibitors effective in the management of the behavioral and psychological symptoms of dementia in Alzheimer's disease? A systematic review of randomized, placebo-controlled trials of donepezil, rivastigmine and galantamine.
    Rodda J; Morgan S; Walker Z
    Int Psychogeriatr; 2009 Oct; 21(5):813-24. PubMed ID: 19538824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.